Charles Cullis Hinckley

Title: Charles Cullis Hinckley: Innovator in PCR Technology

Introduction

Charles Cullis Hinckley is a notable inventor based in Fairport, NY (US). He has made significant contributions to the field of clinical diagnostics, particularly in the area of polymerase chain reaction (PCR) technology. His innovative approach has led to the development of a unique patent that enhances the efficiency of PCR processes.

Latest Patents

Hinckley's most recent patent is titled "Blocked compartments in a PCR reaction vessel." This invention features a flexible cuvette that comprises enclosed chambers and passageways designed for filling and/or passing liquid. The chambers and passageways are formed by plastic sheets that are blocked together prior to use, effectively eliminating air bubbles. This design requires at least 0.8 g/cm of lineal width peel-apart force, ensuring optimal performance during PCR reactions. He holds 1 patent for this innovative technology.

Career Highlights

Charles Cullis Hinckley is currently employed at Johnson & Johnson Clinical Diagnostics, Inc. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field. His contributions have been instrumental in advancing diagnostic technologies that benefit healthcare providers and patients alike.

Collaborations

One of Hinckley's notable coworkers is John B Chemelli. Their collaboration has fostered an environment of innovation and creativity, leading to advancements in clinical diagnostics.

Conclusion

Charles Cullis Hinckley is a distinguished inventor whose work in PCR technology has made a significant impact in the field of clinical diagnostics. His innovative patent demonstrates his commitment to improving diagnostic processes, ultimately benefiting the healthcare industry.